JP2025107171A5 - - Google Patents
Info
- Publication number
- JP2025107171A5 JP2025107171A5 JP2025029903A JP2025029903A JP2025107171A5 JP 2025107171 A5 JP2025107171 A5 JP 2025107171A5 JP 2025029903 A JP2025029903 A JP 2025029903A JP 2025029903 A JP2025029903 A JP 2025029903A JP 2025107171 A5 JP2025107171 A5 JP 2025107171A5
- Authority
- JP
- Japan
- Prior art keywords
- fam3b
- pharmaceutical composition
- vector
- polynucleotide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1906052.4A GB201906052D0 (en) | 2019-04-30 | 2019-04-30 | Proteins with cardioprotective activity |
| GB1906052.4 | 2019-04-30 | ||
| JP2021564417A JP7707075B2 (ja) | 2019-04-30 | 2020-04-30 | 心臓保護的活性のあるタンパク質 |
| PCT/EP2020/062156 WO2020221906A1 (en) | 2019-04-30 | 2020-04-30 | Proteins with cardioprotective activity |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564417A Division JP7707075B2 (ja) | 2019-04-30 | 2020-04-30 | 心臓保護的活性のあるタンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025107171A JP2025107171A (ja) | 2025-07-17 |
| JP2025107171A5 true JP2025107171A5 (enExample) | 2025-10-09 |
Family
ID=66589570
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564417A Active JP7707075B2 (ja) | 2019-04-30 | 2020-04-30 | 心臓保護的活性のあるタンパク質 |
| JP2025029903A Pending JP2025107171A (ja) | 2019-04-30 | 2025-02-27 | 心臓保護的活性のあるタンパク質 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564417A Active JP7707075B2 (ja) | 2019-04-30 | 2020-04-30 | 心臓保護的活性のあるタンパク質 |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US12569574B2 (enExample) |
| EP (2) | EP3962534B1 (enExample) |
| JP (2) | JP7707075B2 (enExample) |
| KR (2) | KR20220027829A (enExample) |
| CN (2) | CN120518738A (enExample) |
| AU (1) | AU2020267029A1 (enExample) |
| BR (1) | BR112021021626A2 (enExample) |
| CA (1) | CA3137662A1 (enExample) |
| DK (1) | DK3962534T3 (enExample) |
| ES (1) | ES2975422T3 (enExample) |
| FI (1) | FI3962534T3 (enExample) |
| GB (1) | GB201906052D0 (enExample) |
| HR (1) | HRP20240441T1 (enExample) |
| HU (1) | HUE066324T2 (enExample) |
| IL (1) | IL287525A (enExample) |
| LT (1) | LT3962534T (enExample) |
| MX (2) | MX2021013298A (enExample) |
| PL (1) | PL3962534T3 (enExample) |
| PT (1) | PT3962534T (enExample) |
| RS (1) | RS65469B1 (enExample) |
| SG (1) | SG11202111267WA (enExample) |
| SI (1) | SI3962534T1 (enExample) |
| SM (1) | SMT202400151T1 (enExample) |
| WO (1) | WO2020221906A1 (enExample) |
| ZA (2) | ZA202107778B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201906052D0 (en) | 2019-04-30 | 2019-06-12 | Int Centre For Genetic Engineering And Biotechnology | Proteins with cardioprotective activity |
| WO2025253097A1 (en) * | 2024-06-03 | 2025-12-11 | Forcefield Therapeutics Limited | Proteins with cardiopreservation activity |
| GB202415505D0 (en) * | 2024-10-21 | 2024-12-04 | King S College London | Lipid nanoparticles for cardiac protection |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2416538A1 (en) * | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| AU2003265867A1 (en) * | 2002-08-29 | 2004-10-18 | Oxford Glycosciences (Uk) Ltd. | A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use |
| US7312079B1 (en) * | 2005-10-06 | 2007-12-25 | Lexicon Pharmaceuticals, Inc. | Variants of FAM3C |
| DK2623605T3 (en) | 2007-04-09 | 2019-03-25 | Univ Florida | RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF |
| US20130136738A1 (en) * | 2010-01-26 | 2013-05-30 | Zhaodan Cao | Methods of Treating Glucose Metabolism Disorders |
| EP2533796A4 (en) * | 2010-02-12 | 2013-12-04 | Ngm Biopharmaceuticals Inc | METHOD FOR THE TREATMENT OF GLUCOSE TISSUE CHANGES |
| KR102248900B1 (ko) | 2011-09-30 | 2021-05-07 | 소마로직, 인크. | 심혈관 위험 사건 예측 및 그것의 용도 |
| ITRM20110685A1 (it) | 2011-12-23 | 2013-06-24 | Internat Ct For Genetic En Gineering And | Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci |
| EP2981334A4 (en) * | 2013-04-03 | 2016-11-23 | Univ California | COMPOSITIONS AND METHODS FOR INHIBITING VIRAL ACTIVITY |
| US20170209621A1 (en) * | 2016-01-21 | 2017-07-27 | The Board Of Trustees Of The Leland Stanford Junior University | Use of chordin-like 1 or collagen vi with mesenchymal stem cells |
| KR102022021B1 (ko) * | 2018-01-10 | 2019-09-18 | 한국과학기술연구원 | 심혈관 질환의 진단을 위한 바이오마커 및 이의 용도 |
| GB201906052D0 (en) | 2019-04-30 | 2019-06-12 | Int Centre For Genetic Engineering And Biotechnology | Proteins with cardioprotective activity |
-
2019
- 2019-04-30 GB GBGB1906052.4A patent/GB201906052D0/en not_active Ceased
-
2020
- 2020-04-30 WO PCT/EP2020/062156 patent/WO2020221906A1/en not_active Ceased
- 2020-04-30 RS RS20240413A patent/RS65469B1/sr unknown
- 2020-04-30 SM SM20240151T patent/SMT202400151T1/it unknown
- 2020-04-30 BR BR112021021626A patent/BR112021021626A2/pt unknown
- 2020-04-30 CN CN202510498600.3A patent/CN120518738A/zh active Pending
- 2020-04-30 FI FIEP20721637.5T patent/FI3962534T3/fi active
- 2020-04-30 SI SI202030402T patent/SI3962534T1/sl unknown
- 2020-04-30 DK DK20721637.5T patent/DK3962534T3/da active
- 2020-04-30 KR KR1020217038850A patent/KR20220027829A/ko not_active Ceased
- 2020-04-30 LT LTEPPCT/EP2020/062156T patent/LT3962534T/lt unknown
- 2020-04-30 AU AU2020267029A patent/AU2020267029A1/en active Pending
- 2020-04-30 PT PT207216375T patent/PT3962534T/pt unknown
- 2020-04-30 HR HRP20240441TT patent/HRP20240441T1/hr unknown
- 2020-04-30 CA CA3137662A patent/CA3137662A1/en active Pending
- 2020-04-30 CN CN202080032910.1A patent/CN113795504B/zh active Active
- 2020-04-30 US US17/606,080 patent/US12569574B2/en active Active
- 2020-04-30 SG SG11202111267WA patent/SG11202111267WA/en unknown
- 2020-04-30 EP EP20721637.5A patent/EP3962534B1/en active Active
- 2020-04-30 EP EP24157959.8A patent/EP4389211A3/en active Pending
- 2020-04-30 MX MX2021013298A patent/MX2021013298A/es unknown
- 2020-04-30 ES ES20721637T patent/ES2975422T3/es active Active
- 2020-04-30 KR KR1020267019357A patent/KR20260099232A/ko active Pending
- 2020-04-30 JP JP2021564417A patent/JP7707075B2/ja active Active
- 2020-04-30 HU HUE20721637A patent/HUE066324T2/hu unknown
- 2020-04-30 PL PL20721637.5T patent/PL3962534T3/pl unknown
-
2021
- 2021-10-13 ZA ZA2021/07778A patent/ZA202107778B/en unknown
- 2021-10-24 IL IL287525A patent/IL287525A/en unknown
- 2021-10-29 MX MX2026002607A patent/MX2026002607A/es unknown
-
2022
- 2022-08-16 US US17/820,243 patent/US12121594B2/en active Active
-
2023
- 2023-10-12 ZA ZA2023/09540A patent/ZA202309540B/en unknown
-
2024
- 2024-09-06 US US18/827,357 patent/US20250057982A1/en active Pending
-
2025
- 2025-02-27 JP JP2025029903A patent/JP2025107171A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2332057T3 (es) | Muteinas del factor de crecimiento de fibroblastos 21. | |
| JP2021121638A5 (enExample) | ||
| JP2025184979A5 (enExample) | ||
| JP2022530824A5 (enExample) | ||
| JP2022520232A5 (enExample) | ||
| JP2022527199A5 (enExample) | ||
| JP2022513308A5 (enExample) | ||
| JP2024511163A5 (enExample) | ||
| JPS60192598A (ja) | 心房ペプチド | |
| KR20160137908A (ko) | 당뇨병-연관 심기능 장애 및 울혈성 심부전을 치료하기 위한 우로코르틴-2 및 연관 유전자들을 인코딩하는 바이러스 벡터들의 전신 전달 | |
| JP2022530168A5 (enExample) | ||
| JP2024513907A5 (enExample) | ||
| EP3778629B1 (en) | Application of ryr2 protein or recombinant ryr2 protein in preparing anti-heart failure medicament | |
| JP2002539781A5 (enExample) | ||
| PT98695A (pt) | Gene codificador do factor neurotrofico de ligacao a heparina | |
| FI3962534T3 (fi) | Proteiineja, joilla on kardioprotektiivinen vaikutus | |
| CN117899223B (zh) | 以nup35基因和或以nup35蛋白作为作用靶点的物质的应用及组合物 | |
| WO2026017126A1 (zh) | 一种人工设计的新型nrg-1在疾病治疗中的应用 | |
| Pring-kerblom et al. | The hexon genes of adenoviruses of subgenus C: comparison of the variable regions | |
| WO2000065043A1 (fr) | Utilisation d'adenovirus recombinant defectif comprenant un acide nucleique codant pour un facteur angiogenique pour le traitement de l'hypertension arterielle pulmonaire | |
| CN103173451B (zh) | 一种心肌特异启动子 | |
| JP2024521063A5 (enExample) | ||
| JP2022530359A5 (enExample) | ||
| IL321129A (en) | Recombinant adenovirus gene therapy vectors with reduced liver tropism and enhanced cardiac cell transduction for the treatment of cardiac diseases and diseases associated with cardiac dysfunction | |
| CN120035671A (zh) | 工程化的肝脏特异性核心启动子及其应用 |